A.K.Byg ApS: Financial statements 2019
CVR: 37611123
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
A.K.Byg ApS (CVR 37611123) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -510,182 the year before. Equity in the 2019 report amounted to DKK -550,013.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK -550,013
- Total Assets
- DKK 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 0 | 0 | -550 t. | - |
| 2018 | - | -508 t. | -510 t. | -550 t. | - |
| 2017 | 0 | -27 t. | -27 t. | -40 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
On June 5, 2019, the company changed its name from Receptor Oncology IVS to Datoselskabet 5. juni IVS.
A.K.Byg ApS has published its annual report for 2018. Gross profit came to DKK -507,906, and the net result was DKK -510,182.
About A.K.Byg ApS
A.K.Byg ApS was a Danish company of the type Anpartsselskab based in Brøndby, founded in 2016. The company has been dissolved on 12 May 2023. The company was registered under the industry Murere. The company was previously named A.K.Byg IVS and Datoselskabet 5. juni IVS. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2020 report amounted to DKK -550,013.